Are Healthscope Limited shares a buy as takeover talks continue?

All eyes have been on Healthscope Limited (ASX: HSO) since the company announced a takeover offer from Canadian investment firm, Brookfield, on February 1.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Australian share market has had its best start to the year since 1991. Driven by gains in financial, telco, retail, healthcare and mining stocks, the Australian sharemarket rose 9.5% in the first quarter.

In the healthcare sector, all eyes have been on Healthscope Limited (ASX: HSO) since the company announced the Canadian investment firm, Brookfield's takeover offer on February 1.

Year to date, the Healthscope share price has increased by 10.5% to its current price of $2.45. Unsurprisingly, most of the growth in the company's share price this year happened on the announcement of the takeover offer.

What's happening with the takeover talks between Healthscope and Brookfield?

Brookfield received approval from the Foreign Investment Review Board (FIRB) to acquire Healthscope Limited in mid-March.

Following the FIRB approval, the Australian Securities and Investments Commission (ASIC) gave Brookfield until April 24 to release the offer documents. Brookfield was given this extra time, compared to the usual two months, as Healthscope wants an independent expert to review the offer documents.

In a nutshell, the public won't know much until April 24 when the offer documents are released.

Should you buy Healthscope shares right now?

Given the uncertainty about whether Brookfield will acquire 100% or 50.1% of Healthscope, I think it would be wise to stay on the sidelines until a decision is made. And while you're waiting, look into CSL Limited (ASX: CSL), Estia Health Ltd (ASX: EHE), or Ramsay Health Care Ltd (ASX: RHC). Year to date, these companies have had solid growth in their share prices:

  • CSL Limited share price is up 7.65%
  • Estia Health Ltd share price is up 14.99%
  • Ramsay Health Care Ltd share price is up 9.6%

Foolish takeaway

As you're researching shares, you may come across a company you're interested in and find out it's in takeover talks just like Healthscope.

While it can be tempting to jump in on the action as the company's name is splashed around in the news, I think it's best to wait until a decision is made and the hype dies down. This is particularly important for investors with a low appetite for risk as share prices can move violently during a takeover.

If you have a higher risk appetite and you're looking to profit from an industry set to take Australia by storm, check out this ASX company.

Motley Fool contributor Nicola Smith has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Shot of a mature scientists working on a laptop in a lab.
Healthcare Shares

Is this a new threat for CSL shares?

There's a new wonder drug on the scene. Should shareholders be concerned?

Read more »

a man in a shirt and tie holds his chin in thoughtful contemplation and looks skywards as if thinking about something while a graphic of a road with many ups and downs unfurls behind him.
Earnings Results

What's with the Neuren Pharmaceuticals share price today?

The full market reaction to the Daybue developer's FY23 earnings report won't be seen until tomorrow.

Read more »

private health insurance diagram.
Healthcare Shares

What's going on with the Medibank share price today?

Shareholders will be happy to see Medibank shares drop in value today.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Earnings Results

Mesoblast share price tumbles on US$32.5m half-year loss

This biotech continues to burn cash.

Read more »

Health professional working on his laptop.
Healthcare Shares

Ramsay Health Care share price falls on profit crunch and dividend cut

This private hospital operator continues to battle with higher costs.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Healthcare Shares

Guess which ASX pharmaceuticals stock is up 400% in 2 days

Big returns have been generated from this pharma stock this week.

Read more »

A man in a white coat holds a laptop in one hand and his head in the other, it's bad news.
Healthcare Shares

Why is this ASX 200 pharmaceuticals stock crashing 15% today?

Investors haven't responded positively to a sales update.

Read more »

A little girl with red hair runs excitedly with a rocket strapped to her back, trying to launch.
Share Gainers

This small-cap ASX stock just rocketed 39%. What's doing?

A stock no one has heard of is lighting up trading screens on Wednesday. You might hear this name more…

Read more »